PET for diagnosis of malignant lymphoma of the scalp: Comparison of [11C]methyl-L-methionine and [18F]fluoro-2-deoxyglucose

Journal of Computer Assisted Tomography

Volumn 21, Issue 4, 1997, Pages 590-593

  Tsuyuguchi, Naohiro ^a   Hakuba, Akira ^a   Okamura, Terue ^a   Ochi, Hironobu ^a   Suzuki, Toshihisa ^b   Sunada, Ichiro ^c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Urology Tane General Hospital   (Japan)

^c Saiseikai Ibaragi Hospital   (Japan)

Author keywords

Fluorodeoxyglucose; Lymphoma; Methionine; Positron emission computed tomography

Indexed keywords

AMINO ACIDS; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY;

B CELLS; EMISSION COMPUTED TOMOGRAPHY; FLUORODEOXYGLUCOSE; L-METHIONINE; LYMPHOMA; MALIGNANT LYMPHOMAS; METHIONINE; POSITRON EMISSION; POSITRON EMISSION COMPUTED TOMOGRAPHY; TUMOR MASS;

TUMORS;

FLUORODEOXYGLUCOSE F 18; S METHYLMETHIONINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CASE REPORT; COMPARATIVE STUDY; FEMALE; HUMAN; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCALP TUMOR; SKULL; TUMOR BIOPSY;

EID: 0030844945     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199707000-00011     Document Type: Article

References (16)

1. National Cancer Institute. Study of classifications on non-Hodgkin's lymphomas: summary and description of a working information for clinical usage. Cancer 1982;49:2112-35.
2. Holtas S, Monajati A, Utz R. Computed tomography of malignant lymphoma involving the skull. J Comput Assist Tomogr 1985;9:725-7.
3. Braunstein EM, White SJ. Non-Hodgkin lymphoma of bone. Radiology 1980;135:59-63.
4. Tanaka S, Nihei H, Manaka S, Hori T. A case of malignant lymphoma in the skull base. No Shinkei Geka 1994;22:73-8.
5. Kumon Y, Sasaki S, Nakano K, Fukui K, Kohno H, Kurihara K. Primary malignant lymphoma of the skull presenting as a growing mass in the forehead. No Shinkei Geka 1991; 19:279-83
6. Ngan H, Preston BJ. Non-Hodgkin's lymphoma presenting with osseous lesions. Clin Radiol 1975;26:351-6.
7. Holtas SL, Kido DK, Simon JH. MR imaging of spinal lymphoma. J Comput Assist Tomogr 1986;10:111-5.
8. Morioka T, Tashima T, Nishio S, Nishie E, Fukui M, Okamura T. Malignant lymphoma of the scalp at the site of a previous blunt trauma: report of two cases. Surg Neurol 1994;42:117-20.
9. Mambo NC, Burke JS, Butler JJ. Primary malignant lymphomas of the breast. Cancer 1977;39:2033-40.
10. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer 1972;29:1905-12.
11. Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 1992;33:532-6.
12. 18F]FDG uptake in primary cerebral lymphoma: a PET study. J Comput Assist Tomogr 1988;12:47-8.
13. Okada J, Oonishi H, Yoshikawa K, et al. FDG-PET for predicting the prognosis of malignant lymphoma. Ann Nucl Med 1994;8:183-6.
14. Okada J, Yoshikawa K, Imazeki K, et al. The use of FDG-PET in the detection and management of lymphoma: correlation of uptake with prognosis. J Nucl Med 1991;32:686-91.
15. 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma. Neuroradiology 1992;34:517-9.
16. Leskinen-Kallio S, Ruotsalainen U, Nagren K, Teraes M, Joensusu H. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med 1991;32:1211-8.